These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21292131)

  • 1. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy.
    Trucco SM; Jaeggi E; Cuneo B; Moon-Grady AJ; Silverman E; Silverman N; Hornberger LK
    J Am Coll Cardiol; 2011 Feb; 57(6):715-23. PubMed ID: 21292131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
    Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
    Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.
    Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL
    Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment.
    Mawad W; Hornberger L; Cuneo B; Raboisson MJ; Moon-Grady AJ; Lougheed J; Diab K; Parkman J; Silverman E; Jaeggi E
    J Am Heart Assoc; 2022 Feb; 11(3):e023000. PubMed ID: 35001672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.
    Nield LE; Silverman ED; Taylor GP; Smallhorn JF; Mullen JB; Silverman NH; Finley JP; Law YM; Human DG; Seaward PG; Hamilton RM; Hornberger LK
    Circulation; 2002 Feb; 105(7):843-8. PubMed ID: 11854125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
    Saleeb S; Copel J; Friedman D; Buyon JP
    Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.
    Eliasson H; Sonesson SE; Sharland G; Granath F; Simpson JM; Carvalho JS; Jicinska H; Tomek V; Dangel J; Zielinsky P; Respondek-Liberska M; Freund MW; Mellander M; Bartrons J; Gardiner HM;
    Circulation; 2011 Nov; 124(18):1919-26. PubMed ID: 21986286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.
    Pisoni CN; Brucato A; Ruffatti A; Espinosa G; Cervera R; Belmonte-Serrano M; Sánchez-Román J; García-Hernández FG; Tincani A; Bertero MT; Doria A; Hughes GR; Khamashta MA
    Arthritis Rheum; 2010 Apr; 62(4):1147-52. PubMed ID: 20131278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
    Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block.
    Nield LE; Silverman ED; Smallhorn JF; Taylor GP; Mullen JB; Benson LN; Hornberger LK
    J Am Coll Cardiol; 2002 Aug; 40(4):796-802. PubMed ID: 12204513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.
    Ruma MS; Moise KJ; Kim E; Murtha AP; Prutsman WJ; Hassan SS; Lubarsky SL
    Am J Obstet Gynecol; 2007 Feb; 196(2):138.e1-6. PubMed ID: 17306655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy.
    Kan N; Silverman ED; Kingdom J; Dutil N; Laskin C; Jaeggi E
    Prenat Diagn; 2017 Apr; 37(4):375-382. PubMed ID: 28177533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies.
    Raboisson MJ; Fouron JC; Sonesson SE; Nyman M; Proulx F; Gamache S
    J Am Soc Echocardiogr; 2005 Apr; 18(4):375-80. PubMed ID: 15846168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies.
    Guettrot-Imbert G; Cohen L; Fermont L; Villain E; Francès C; Thiebaugeorges O; Foliguet B; Leroux G; Cacoub P; Amoura Z; Piette JC; Costedoat-Chalumeau N
    J Rheumatol; 2011 Feb; 38(2):378-86. PubMed ID: 21078712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review.
    Hutter D; Silverman ED; Jaeggi ET
    Scand J Immunol; 2010 Sep; 72(3):235-41. PubMed ID: 20696021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow up of children after antenatal treatment for alloimmune thrombocytopenia.
    Radder CM; de Haan MJ; Brand A; Stoelhorst GM; Veen S; Kanhai HH
    Early Hum Dev; 2004 Oct; 80(1):65-76. PubMed ID: 15363839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal treatment of alloimmune thrombocytopenia.
    Lynch L; Bussel JB; McFarland JG; Chitkara U; Berkowitz RL
    Obstet Gynecol; 1992 Jul; 80(1):67-71. PubMed ID: 1603500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].
    Zemlin M; Bauer K; Dörner T; Altinöz H; Versmold H
    Z Geburtshilfe Neonatol; 2002; 206(1):22-5. PubMed ID: 11887252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.